Lakewood-Amedex Biotherapeutics Inc. share price logo

Lakewood-Amedex Biotherapeutics Inc.

NASDAQ: LABT

$2.07

-0.25

(-10.78%)

as on

Lakewood-Amedex Biotherapeutics Inc. Stock Performance

as on September 11, 2026 at 6:59 am IST

  • Day's Low

    Day's High

    $2.03
    $2.30
    downward going graph

    1.93%

    Downside

    11.11%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    downward going graph

    100.00%

    Downside

    -100.00%

    Upside

    downward going graph

Lakewood-Amedex Biotherapeutics Inc. share price movements today

Previous Close
$2.32
Open
$2.24
Volume
571.2K
Market Cap
$5.2M
Day's Low - High
$2.03 - $2.30

Lakewood-Amedex Biotherapeutics Inc. Historical Returns

1 Month Return
-1.28 %
3 Month Return
-69.42 %
1 Year Return
0 %
3 Year Return
0 %
5 Year Return
0 %

Lakewood-Amedex Biotherapeutics Inc. Stock Fundamentals & Key Indicators

Check Lakewood-Amedex Biotherapeutics Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$5.2M

EPS (TTM)

-10.02

Dividend Yield

0.00%

PE Ratio (TTM)

-0.23

Industry PE ratio

-1.62

PEG Ratio

0.002699404476451844

Return On Equity TTM

1687.68%

Lakewood-Amedex Biotherapeutics Inc. Stock Valuation

Track how Lakewood-Amedex Biotherapeutics Inc. P/E has moved over time to understand its valuation trends.

Lakewood-Amedex Biotherapeutics Inc. in the last 1 year

  • Overview

  • Trends

Lowest (-31.34x)

December 31, 2025

Today (-31.34x)

December 31, 2025

Industry (-1.62x)

December 31, 2025

Highest (-31.34x)

December 31, 2025

LowHigh

Today’s Price to Earnings Ratio: -31.34x

Lakewood-Amedex Biotherapeutics Inc. vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Lakewood-Amedex Biotherapeutics Inc. with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
NA$5.2MNA-0.230.00%NA
BUY$44.6B614.61%NA0.00%NA
BUY$138.4B181.2%30.5486.04%NA
BUY$56.0B-69.82%-16.99-12.57%NA
BUY$85.2B24.16%19.2884.86%45.660000000000004%

Indian Investors' Interest in Lakewood-Amedex Biotherapeutics Inc. Stock

Search interest for Lakewood-Amedex Biotherapeutics Inc. Stock has decreased by -81% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-81% versus previous 30 day period

Lakewood-Amedex Biotherapeutics Inc. Quarterly Profit & Loss

All numbers in Millions USD

Sep 2025
Dec 2025
Mar 2026
Jun 2026
Total Revenue
-
-
-
-
Gross Profit
-
0
-
-
Operating Income
-1
0
0
-3
EBITDA
-1
0
0
-3
Interest Expense
0
0
0
0
Depreciation
0
0
0
-
Income Before Tax
-1
0
0
-3
Income Tax Expense
-
-
-
-
Net Income
-1
0
0
-3
Net Profit Margin
0.00%
0.00%
0.00%
0.00%

Lakewood-Amedex Biotherapeutics Inc. Annual Profit & Loss

All numbers in Millions USD

Dec 2025
Total Revenue
-
Gross Profit
-
Operating Income
-3
EBITDA
-3
Interest Expense
0
Depreciation
0
Income Before Tax
-3
Income Tax Expense
-
Net Income
-3
Net Profit Margin
0.00%

Lakewood-Amedex Biotherapeutics Inc. Quarterly Cash Flow

All numbers in Millions USD

Sep 2025
Dec 2025
Mar 2026
Jun 2026
Net Income
-1
0
0
-3
Operating Cash Flow
0
0
0
-2
Investing Cash Flow
-
-
-
-2
Financing Cash Flow
-
-
0
6
Change in Cash
0
0
0
2

Lakewood-Amedex Biotherapeutics Inc. Annual Cash Flow

All numbers in Millions USD

Dec 2025
Net Income
-3
Operating Cash Flow
-1
Investing Cash Flow
-
Financing Cash Flow
1
Change in Cash
0

Global Institutional Holdings in Lakewood-Amedex Biotherapeutics Inc.

Funds
Holdings
Ronald Blue Trust, Inc.
0%

Insights on Lakewood-Amedex Biotherapeutics Inc.

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 7 days, LABT stock has moved up by 23.4%

About Lakewood-Amedex Biotherapeutics Inc.

Lakewood-Amedex Biotherapeutics, Inc. operates as a clinical-stage biotechnology company that develops antimicrobial products in the United States. The company offers products from its Bisphosphocin class, a novel class of antimicrobial agents a broad range of infections, including those affecting the skin, bladder, and lungs. It also develops Nu-3, a topical antimicrobial for infected diabetic foot ulcers, which is in Phase 2b clinical trial. The company was formerly known as Lakewood-Amedex Inc. and changed its name to Lakewood-Amedex Biotherapeutics, Inc. in June 2025. Lakewood-Amedex Biotherapeutics, Inc. was incorporated in 2006 and is headquartered in University Park, Florida.
OrganisationLakewood-Amedex Biotherapeutics Inc.
Headquarters8031 Cooper Creek Blvd., University Park, FL, United States, 34201
IndustryBiotechnology
CEODr. Kelvin Cooper Ph.D.
E-voting on sharesClick here to vote

Key Management of Lakewood-Amedex Biotherapeutics Inc.

Name

Title

Daniel Kontoh-Boateng

Investor Relations

Dr. Kelvin Cooper Ph.D.

CEO, SVP of Research & Development and Director

Mr. Peter F. Ceccacci

CFO & VP of Administration

Dr. Thomas Balzer M.D., Ph.D.

Chief Medical Officer & SVP of Clinical Development

Ms. Tara Endress

Project Manager & Accounting Manager

FAQs

What is Lakewood-Amedex Biotherapeutics Inc. share price today?

Lakewood-Amedex Biotherapeutics Inc. share price today is $2.07 as on at the close of the market. Lakewood-Amedex Biotherapeutics Inc. share today touched a day high of $2.30 and a low of $2.03.

What is the 52 week high and 52 week low for Lakewood-Amedex Biotherapeutics Inc. share?

Lakewood-Amedex Biotherapeutics Inc. share touched a 52 week high of $0.00 on and a 52 week low of $0.00 on . Lakewood-Amedex Biotherapeutics Inc. stock price today i.e. is closed at $2.07,which is -Infinity% down from its 52 week high and Infinity% up from its 52 week low.

What is Lakewood-Amedex Biotherapeutics Inc.'s market capitalisation today?

Lakewood-Amedex Biotherapeutics Inc. market capitalisation is $0.00T as on .

How to invest in Lakewood-Amedex Biotherapeutics Inc. Stock (LABT) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Lakewood-Amedex Biotherapeutics Inc. on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Lakewood-Amedex Biotherapeutics Inc. Shares that will get you 0.7246 shares as per Lakewood-Amedex Biotherapeutics Inc. share price of $2.07 per share as on September 11, 2026 at 1:29 am IST.

What is the minimum amount required to buy Lakewood-Amedex Biotherapeutics Inc. Stock (LABT) from India?

Indian investors can start investing in Lakewood-Amedex Biotherapeutics Inc. (LABT) shares with as little as ₹95.43 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹954.30 in Lakewood-Amedex Biotherapeutics Inc. stock (as per the Rupee-Dollar exchange rate as on ). Based on Lakewood-Amedex Biotherapeutics Inc. share’s latest price of $2.07 as on September 11, 2026 at 1:29 am IST, you will get 4.8309 shares of Lakewood-Amedex Biotherapeutics Inc.. Learn more about fractional shares .